An Important History Lesson for Gene-Editing Investors
https://www.fool.com/investing/2023/12/02/an-important-history-lesson-for-gene-editing-inves/?source=iedfolrf0000001
Dec 02, 2023 - Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.
0
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
https://www.fool.com/investing/2023/12/18/these-are-the-3-hottest-biopharma-trends-of-2024/?source=iedfolrf0000001
Dec 18, 2023 - 2024 is going to be a sizzler in the biopharma sector.
0
Why Novo Nordisk Stock Was Up on a Down Day for the Market
https://www.fool.com/investing/2023/12/20/why-novo-nordisk-stock-was-up-on-a-down-day-for-th/?source=iedfolrf0000001
Dec 20, 2023 - As if the company's top two products weren't popular enough, a new media report made them even more appealing.
0
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
https://www.fool.com/investing/2023/12/21/weighing-their-chances-5-leading-healthcare-compan/?source=iedfolrf0000001
Dec 21, 2023 - Which weight-loss stocks are good buys today?
0
The Best Stocks to Invest $1,000 in Right Now
https://www.fool.com/investing/2024/01/04/the-best-stocks-to-invest-1000-in-right-now/?source=iedfolrf0000001
Jan 04, 2024 - It's not too late to get in on these market beaters.
0
Novo Nordisk (NVO) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/01/31/novo-nordisk-nvo-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Jan 31, 2024 - NVO earnings call for the period ending December 31, 2023.
0
Novo Nordisk's Magic Run Continues Even With Increasing Competition
https://www.fool.com/investing/2024/02/12/novo-nordisks-magic-run-continues-even-with/?source=iedfolrf0000001
Feb 12, 2024 - Novo Nordisk's Q4 earnings were rock solid as momentum in the diabetes and obesity markets continued to fuel growth.
0
Novo Nordisk Has More Than Ozempic. One of Its Other Treatments Grew 393% Last Year.
https://www.fool.com/investing/2024/02/18/novo-nordisk-has-more-than-ozempic-one-of-its/?source=iedfolrf0000001
Feb 18, 2024 - It may be best known for its diabetes treatment, Ozempic, but Novo Nordisk has a host of other blockbuster drugs, too.
0
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
https://www.fool.com/investing/2024/03/22/with-shares-near-all-time-highs-is-it-a-buy/?source=iedfolrf0000001
Mar 22, 2024 - The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
0
Diversifying Into This Key Market Is 1 More Reason to Buy Novo Nordisk Stock
https://www.fool.com/investing/2024/03/31/diversifying-into-this-key-market-is-1-more-reason/?source=iedfolrf0000001
Mar 31, 2024 - The semaglutide maker just announced a strategic acquisition that will be a green flag for its future value.
0
Page 1>